NEW YORK (GenomeWeb News) — Blue Stream Laboratories has purchased a suite of Agilent Technologies’ proteomics products for its drug-development work, Agilent said today.
 
Boston-based Blue Stream has stocked its protein-characterization lab with Agilent's HPLC-chip and its 6210 time-of-flight mass spectrometer with MALDI and electrospray capabilities.
 
The deal also includes software and services that support the technology, Agilent said.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.

Jun
05
Sponsored by
Linguamatics

This webinar will discuss how Sanofi used literature mining to annotate the association of human leukocyte antigen (HLA) alleles with diseases and drug hypersensitivity as part of a multiple sclerosis (MS) biomarker discovery project.

Jun
12
Sponsored by
Philips Genomics

This webinar will highlight a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.